CDISC’s Requirements About SEND

SEND (Standard for Exchange of Nonclinical Data, Non-Clinical Data Interchange Standards Consortium）Clinical Data Interchange Standards Consortium (Clinical Data Interchange Standards Consortium) Numerical formalism.

On September 15th of this year, the FDA CDER issued an enforcement request IND and an NDA/BLA application, supporting the submission of a non-payment test SEND number (Dataset). The Dataset code for the data set is to be confirmed and sent by the FDA SEND formal communication request.

Mr. Harahara, Director of FDA standardization research. Origin: FDA

When did it Start to Operate the SEND Dataset?

FDA CDER general request IND on September 15, 2021, support NDA/BLA China-China demand negotiations, non-table trial SEND Dataset, including comprehensive GLP and non-GLP trial. If the SEND Dataset cannot be passed, the FDA approval has been rejected.

SENDIG is a reference-specific SDTM model. However, SDTM is a comprehensive model of the original capital. In this case, this small model is compatible with both directions. SENDIG supports multiple-dose general toxicology, multiple-dose general toxicology, carcinogenicity research, and safety science research.

Support for other research categories than SENDIG. For example, SENDIG-DART v1.2 has been established, and DART research collection includes certain specific numerical recommendations, especially embryo-fetal development (EFD) research, and juvenile animal behavioral toxicity research. SENDIG-AR v1.0 Supports the basic infrastructure and ongoing research. In addition to the model implementation guidelines, we will develop the consistency guideline, so you can be sure of the generative number structure combination.

Under what circumstances will FDA refuse to accept a submitted SEND Dataset?

If the submitted SEND Dataset has the following problems, FDA will refuse to accept it:

• Missing corresponding ts.xpt Dataset

• Incorrectly filling in the STF file tag of Dataset

• Missing DM Dataset and define.xml

• Missing STF files

Reference:

[1]. CDISC Website: SEND. https://www.cdisc.org/standards/foundational/send

此博客中的热门博文

Custom Synthesis

Medicilon has synthesized over 10,000 individual compounds from gram to kilogram quantities, and many compounds are synthesized with more than ten synthetic steps. The overall synthesis success rate is over 95%. High quality products from mg to kg scale Reagents, intermediates, building blocks, and scaffolds Preparation of API or reference standards Development of synthetic routes for impurities and metabolites On-site analytical support Product delivered with COA Medicilon offers integrated drug discovery services -- Chemistry, Biology & Preclinical Services

阅读全文

In Vitro Enzyme Activity Assay

Kinases play extensive and important roles in signal transduction and co-ordination of complex functions. Currently, about 300 kinase inhibitors have been approved for marketing, among which receptor tyrosine kinase (RTK) inhibitors are the main ones. Medicilon provides high-quality kinase profile screening and has one-stop kinase research services from assay development, high-throughput screening to selectivity analysis. In addition, Medicilon provides many other enzyme activity screens. Wide Variety Provides 200+ in vitro enzymatic detection methods; 100+ kinases, including CTK, RTK, AGC, CMGC and other kinase families as well as important common mutations Project Flexibility Various types of plates for screening, such as 96 and 384; Multiple flexible kinase profiles, including TK kinase family, CDK kinase family, etc., to meet different customer customization needs. Various Methods Fluorescence detection; Chemiluminescence detection; Absorbance detection LanthaScr...

阅读全文

Pharmacokinetics Services

Pharmacokinetics Services Our pharmacokinetics department offers the clients a broad spectrum of high quality of services in the areas of in vitro ADME, in vivo pharmacokinetics and bioanalysis services, ranging from small molecules to large molecules, such as protein and antibody. The animal species involved in our services are non-human primate, canine, mice, rat, rabbit and hamster. Meanwhile, non-human primate experimental platform and isotope platform for protein/antibody are certified by the Shanghai government. Preclinical Pharmacokinetics Method development and validation (GLP,Non-GLP) Bioanalysis Pharmacokinetics (Tumor bearing rodents, Bioavailability, Crossover studies, Cassette (N in 1) dosing and analysis, effects of gender on pharmacokinetics, BBB penetration ) Stability in vehicles and plasma Drug interaction studies In vitro metabolic stability CYP 450 inhibition Plasma protein binding studies Distribution studies Excretion studies Prediction an...

阅读全文

Shanghai Medicilon Inc.

搜索此博客